STERIS’ (TSE:STE – Free Report) – Cormark reduced their FY2024 earnings per share (EPS) estimates for STERIS’ in a report released on Tuesday, November 5th. Cormark analyst B. Watson now anticipates that the company will post earnings of $0.77 per share for the year, down from their previous forecast of $0.90.
STERIS’ (TSE:STE – Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported C$0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.12 by C$0.02. The business had revenue of C$231.38 million for the quarter, compared to the consensus estimate of C$226.20 million.
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- The Basics of Support and Resistance
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Where to Find Earnings Call Transcripts
- Breakout Alert: Qualcomm Just Hit The Rally Button
- The 3 Best Retail Stocks to Shop for in August
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
